Inventor · disambiguated record
Yanping Xu
Also filed as: XU YANPING
26 granted patents·25 pending applications·85 citations·filing 2000–2023
94Inventor score
Files withLILLY CO ELI20SIRONAX LTD10JANSSEN SCIENCES IRELAND UNLIMITED CO6JANSSEN PHARMACEUTICA NV5SIRONAX BEIJING CO LTD2
Top patents by PatentIndex Score
51 records- 0184US7968585B2Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1LILLY CO ELI·Filed 2007·Granted Jun 28, 2011·7 cites·18 claims
- 0284US6310058B1Antimycobacterial agentsUNIV NOTRE DAME DU LAC·Filed 2000·Granted Oct 30, 2001·16 cites·16 claims
- 0381US7045545B1Aminoalkylbenzofurans as serotonin (5-HT(2c)) agonistsLILLY CO ELI·Filed 2000·Granted May 16, 2006·12 cites·6 claims
- 0479US6967201B1Benzofurylpiperazines and benzofurylhomopiperazines: serotonin agonistsLILLY CO ELI·Filed 2000·Granted Nov 22, 2005·15 cites·9 claims
- 0576US6930120B2Oxazolyl-arylproplonic acid derivatives and their use as ppar agonistsLILLY CO ELI·Filed 2001·Granted Aug 16, 2005·10 cites·20 claims
- 0675US7998999B2Cyclohexyl substituted pyrrolidinones as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1LILLY CO ELI·Filed 2007·Granted Aug 16, 2011·3 cites·14 claims
- 0775US7994176B2Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1LILLY CO ELI·Filed 2007·Granted Aug 9, 2011·2 cites·21 claims
- 0871US7176224B2Oxazolyl-aryloxyacetic acid derivatives and their use as PPAR agonistsLILLY CO ELI·Filed 2001·Granted Feb 13, 2007·6 cites·40 claims
- 0970US7829582B2Piperidinyl substituted pyrrolidinones as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1LILLY CO ELI·Filed 2007·Granted Nov 9, 2010·1 cites·21 claims
- 1070US7655641B2Sulfonamide derivatives as PPAR modulatorsLILLY CO ELI·Filed 2004·Granted Feb 2, 2010·5 cites·19 claims
- 1169US7816349B2Substituted pyrrolidinones as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1LILLY CO ELI·Filed 2007·Granted Oct 19, 2010·1 cites·16 claims
- 1268US7304062B2Peroxisome proliferator activated receptor alpha agonistsLILLY CO ELI·Filed 2001·Granted Dec 4, 2007·4 cites·37 claims
- 1367US7820659B2Cyclohexylimidiazole lactam derivatives as inhibitors of 11-β-hydroxysteroid dehydrogenase 1LILLY CO ELI·Filed 2007·Granted Oct 26, 2010·1 cites·20 claims
- 1462US7544812B2Peroxisome proliferator activated receptor agonistsLILLY CO ELI·Filed 2002·Granted Jun 9, 2009·2 cites·23 claims
- 1559US2025326726A1Ferroptosis inhibitors-phenoxazine acetamidesSIRONAX BEIJING CO LTD·Filed 2023·Application pending·0 cites
- 1658US2024391900A1Rip1 kinase inhibitor and use thereofSIRONAX BEIJING CO LTD·Filed 2022·Application pending·0 cites
- 1755US2025333421A1Pyridazines or 1,2,4-triazines substituted by spirocyclic aminesJANSSEN PHARMACEUTICA NV·Filed 2022·Application pending·0 cites
- 1855US2024417405A1Substituted Spiro DerivativesJANSSEN PHARMACEUTICA NV·Filed 2022·Application pending·0 cites
- 1954US12473295B2Substituted straight chain spiro derivativesJANSSEN PHARMACEUTICA NV·Filed 2020·Granted Nov 18, 2025·0 cites·20 claims
- 2054US2009062358A1Peroxisome proliferator activated receptor alpha agonistsCANO IVAN COLLADO·Filed 2007·Application pending·0 cites
- 2154US2025179061A1Rip1 modulators, preparations, and uses thereofSIRONAX LTD·Filed 2023·Application pending·0 cites
- 2253US11053235B2Substituted 1,4-dihydropyrimidines for the treatment of HBV infection or HBV-induced diseasesJANSSEN SCIENCES IRELAND UNLIMITED CO·Filed 2019·Granted Jul 6, 2021·0 cites·17 claims
- 2352US2022348571A1Dihydropyrimidine derivatives and uses thereof in the treatment of hbv infection or of hbv-induced diseasesJANSSEN SCIENCES IRELAND UNLIMITED CO·Filed 2019·Application pending·0 cites
- 2450US12454529B2Piperazine cyclic ureasSIRONAX LTD·Filed 2021·Granted Oct 28, 2025·0 cites·28 claims
- 2550US2024217963A1Receptor-interacting protein 1 inhibitors, preparations, and uses thereofSIRONAX LTD·Filed 2022·Application pending·0 cites
- 2650US2023002408A1Heteroaryldihydropyrimidine derivatives and methods of treating hepatitis b infectionsJANSSEN PHARMACEUTICA NV·Filed 2020·Application pending·0 cites
- 2750US2024294508A1Rip1 modulators including azetidine cyclic ureas, preparations, and uses thereofSIRONAX LTD·Filed 2022·Application pending·0 cites
- 2849US7345070B2Peroxisome proliferator activated receptor agonistsLILLY CO ELI·Filed 2005·Granted Mar 18, 2008·0 cites·6 claims
- 2949US2024327393A1Ferroptosis modulators, preparations, and uses thereofSIRONAX LTD·Filed 2022·Application pending·0 cites
- 3049US2025236613A1Sarm1 modulators, preparations, and uses thereofSIRONAX LTD·Filed 2022·Application pending·0 cites
- 3149US2025320184A1Sarm1 modulators, preparations, and uses thereofSIRONAX LTD·Filed 2023·Application pending·0 cites
- 3248US7608639B2Phenoxyether derivatives as PPAR modulatorsLILLY CO ELI·Filed 2004·Granted Oct 27, 2009·0 cites·18 claims
- 3348US2022267313A1Dihydropyrimidine derivatives and uses thereof in the treatment of hbv infection or of hbv-induced diseasesJANSSEN SCIENCES IRELAND UNLIMITED CO·Filed 2020·Application pending·0 cites
- 3447US2022348592A1Fused heterocyclic derivativesJANSSEN SCIENCES IRELAND UNLIMITED CO·Filed 2020·Application pending·0 cites
- 3547US2024360114A1Ferroptosis modulators, preparations, and uses thereofSIRONAX LTD·Filed 2022·Application pending·0 cites
- 3646US8148534B2Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1LI RENHUA·Filed 2007·Granted Apr 3, 2012·0 cites·10 claims
- 3746US2023416226A1Azetidine Cyclic UreasSIRONAX LTD·Filed 2021·Application pending·0 cites
- 3846US2023192662A1Receptor-Interacting Protein 1 Inhibitors Including Piperazine Heterocyclic Amide UreasSIRONAX LTD·Filed 2021·Application pending·0 cites
- 3946US2023165865A1Heteroaryldihydropyrimidine derivatives and methods of treating hepatitis b infectionsJANSSEN PHARMACEUTICA NV·Filed 2019·Application pending·0 cites
- 4046US2022281865A1Dihydropyrimidine derivatives and uses thereof in the treatment of hbv infection or of hbv-induced diseasesJANSSEN SCIENCES IRELAND UNLIMITED CO·Filed 2020·Application pending·0 cites
- 4145US7981918B2Cyclohexylpyrazole-lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1LILLY CO ELI·Filed 2007·Granted Jul 19, 2011·0 cites·20 claims
- 4245US2007082907A1Peroxisome proliferator activated receptor modulatorsLILLY CO ELI·Filed 2004·Application pending·0 cites
- 4344US10934280B2Condensed thiophene derivatives useful as NaPi-IIb inhibitorsLILLY CO ELI·Filed 2017·Granted Mar 2, 2021·0 cites·21 claims
- 4444US8088776B2Biphenyl amide lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1AICHER THOMAS DANIEL·Filed 2007·Granted Jan 3, 2012·0 cites·20 claims
- 4544US2022048919A1Heteroaryldihydropyrimidine derivatives and methods of treating hepatitis b infectionsJanssen Phrmaceutica NV·Filed 2019·Application pending·0 cites
- 4643US8153807B2Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1BUSH JULIE KAY·Filed 2007·Granted Apr 10, 2012·0 cites·22 claims
- 4740US2023083012A1Dihydropyrimidine derivatives and uses thereof in the treatment of hbv infection or of hbv-induced diseasesJANSSEN SCIENCES IRELAND UNLIMITED CO·Filed 2020·Application pending·0 cites
- 4839US2006257987A1Ppar modulatorsGONZALEZ VALCARCEL ISABEL CRIS·Filed 2004·Application pending·0 cites
- 4937US7220880B2Amide linker peroxisome proliferator activated receptor modulatorsLILLY CO ELI·Filed 2003·Granted May 22, 2007·0 cites·26 claims
- 5037US6881733B1Serotonergic benzofuransLILLY CO ELI·Filed 2000·Granted Apr 19, 2005·0 cites·18 claims
Showing the top 50 of 51 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Yanping Xu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →